The global Prednisolone Tablets market is projected to grow from US$ 185 million in 2024 to US$ 262 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Prednisolone Tablets Market

Prednisolone is a medicine used to treat a wide range of health problems including allergies, blood disorders, skin diseases, inflammation, infections and certain cancers and to prevent organ rejection after a transplant.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Prednisolone Tablets leading manufacturers including Pfizer, Teva Pharmaceuticals, Harbin Pharmaceutical, Zhejiang Xianju Pharmaceutical, Xi'An Lijun Pharmaceutical, Tianjin Jinjin Pharmaceutical, China Resources Zizhu Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Pfizer leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Prednisolone Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Prednisolone Tablets Market Report

Report Metric	Details
Report Name	Prednisolone Tablets Market
Accounted market size in 2024	US$ 185 million
Forecasted market size in 2031	US$ 262 million
CAGR	5.2%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital Clinic Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Teva Pharmaceuticals, Harbin Pharmaceutical, Zhejiang Xianju Pharmaceutical, Xi'An Lijun Pharmaceutical, Tianjin Jinjin Pharmaceutical, China Resources Zizhu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Prednisolone Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Prednisolone Tablets Market growing?

Ans: The Prednisolone Tablets Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Prednisolone Tablets Market size in 2031?

Ans: The Prednisolone Tablets Market size in 2031 will be US$ 262 million.

Who are the main players in the Prednisolone Tablets Market report?

Ans: The main players in the Prednisolone Tablets Market are Pfizer, Teva Pharmaceuticals, Harbin Pharmaceutical, Zhejiang Xianju Pharmaceutical, Xi'An Lijun Pharmaceutical, Tianjin Jinjin Pharmaceutical, China Resources Zizhu Pharmaceutical

What are the Application segmentation covered in the Prednisolone Tablets Market report?

Ans: The Applications covered in the Prednisolone Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Prednisolone Tablets Market report?

Ans: The Types covered in the Prednisolone Tablets Market report are Original Drug, Generic Drug

1 Study Coverage

1.1 Introduction to Prednisolone Tablets: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Prednisolone Tablets Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Market Segmentation by Application

1.3.1 Global Prednisolone Tablets Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Prednisolone Tablets Revenue Estimates and Forecasts 2020-2031

2.2 Global Prednisolone Tablets Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Prednisolone Tablets Sales Estimates and Forecasts 2020-2031

2.4 Global Prednisolone Tablets Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Prednisolone Tablets Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Prednisolone Tablets Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Original Drug Market Size by Manufacturers

3.5.2 Generic Drug Market Size by Manufacturers

3.6 Global Prednisolone Tablets Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Prednisolone Tablets Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Prednisolone Tablets Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Prednisolone Tablets Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Prednisolone Tablets Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Prednisolone Tablets Sales and Revenue by Type (2020-2031)

6.4 North America Prednisolone Tablets Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Prednisolone Tablets Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Prednisolone Tablets Sales and Revenue by Type (2020-2031)

7.4 Europe Prednisolone Tablets Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Prednisolone Tablets Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Prednisolone Tablets Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Prednisolone Tablets Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Prednisolone Tablets Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Prednisolone Tablets Sales and Revenue by Type (2020-2031)

9.4 Central and South America Prednisolone Tablets Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Prednisolone Tablets Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Prednisolone Tablets Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Prednisolone Tablets Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Prednisolone Tablets Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Pfizer

11.1.1 Pfizer Corporation Information

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Prednisolone Tablets Product Models, Descriptions and Specifications

11.1.4 Pfizer Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Pfizer Prednisolone Tablets Sales by Product in 2024

11.1.6 Pfizer Prednisolone Tablets Sales by Application in 2024

11.1.7 Pfizer Prednisolone Tablets Sales by Geographic Area in 2024

11.1.8 Pfizer Prednisolone Tablets SWOT Analysis

11.1.9 Pfizer Recent Developments

11.2 Teva Pharmaceuticals

11.2.1 Teva Pharmaceuticals Corporation Information

11.2.2 Teva Pharmaceuticals Business Overview

11.2.3 Teva Pharmaceuticals Prednisolone Tablets Product Models, Descriptions and Specifications

11.2.4 Teva Pharmaceuticals Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Teva Pharmaceuticals Prednisolone Tablets Sales by Product in 2024

11.2.6 Teva Pharmaceuticals Prednisolone Tablets Sales by Application in 2024

11.2.7 Teva Pharmaceuticals Prednisolone Tablets Sales by Geographic Area in 2024

11.2.8 Teva Pharmaceuticals Prednisolone Tablets SWOT Analysis

11.2.9 Teva Pharmaceuticals Recent Developments

11.3 Harbin Pharmaceutical

11.3.1 Harbin Pharmaceutical Corporation Information

11.3.2 Harbin Pharmaceutical Business Overview

11.3.3 Harbin Pharmaceutical Prednisolone Tablets Product Models, Descriptions and Specifications

11.3.4 Harbin Pharmaceutical Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Harbin Pharmaceutical Prednisolone Tablets Sales by Product in 2024

11.3.6 Harbin Pharmaceutical Prednisolone Tablets Sales by Application in 2024

11.3.7 Harbin Pharmaceutical Prednisolone Tablets Sales by Geographic Area in 2024

11.3.8 Harbin Pharmaceutical Prednisolone Tablets SWOT Analysis

11.3.9 Harbin Pharmaceutical Recent Developments

11.4 Zhejiang Xianju Pharmaceutical

11.4.1 Zhejiang Xianju Pharmaceutical Corporation Information

11.4.2 Zhejiang Xianju Pharmaceutical Business Overview

11.4.3 Zhejiang Xianju Pharmaceutical Prednisolone Tablets Product Models, Descriptions and Specifications

11.4.4 Zhejiang Xianju Pharmaceutical Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Zhejiang Xianju Pharmaceutical Prednisolone Tablets Sales by Product in 2024

11.4.6 Zhejiang Xianju Pharmaceutical Prednisolone Tablets Sales by Application in 2024

11.4.7 Zhejiang Xianju Pharmaceutical Prednisolone Tablets Sales by Geographic Area in 2024

11.4.8 Zhejiang Xianju Pharmaceutical Prednisolone Tablets SWOT Analysis

11.4.9 Zhejiang Xianju Pharmaceutical Recent Developments

11.5 Xi'An Lijun Pharmaceutical

11.5.1 Xi'An Lijun Pharmaceutical Corporation Information

11.5.2 Xi'An Lijun Pharmaceutical Business Overview

11.5.3 Xi'An Lijun Pharmaceutical Prednisolone Tablets Product Models, Descriptions and Specifications

11.5.4 Xi'An Lijun Pharmaceutical Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Xi'An Lijun Pharmaceutical Prednisolone Tablets Sales by Product in 2024

11.5.6 Xi'An Lijun Pharmaceutical Prednisolone Tablets Sales by Application in 2024

11.5.7 Xi'An Lijun Pharmaceutical Prednisolone Tablets Sales by Geographic Area in 2024

11.5.8 Xi'An Lijun Pharmaceutical Prednisolone Tablets SWOT Analysis

11.5.9 Xi'An Lijun Pharmaceutical Recent Developments

11.6 Tianjin Jinjin Pharmaceutical

11.6.1 Tianjin Jinjin Pharmaceutical Corporation Information

11.6.2 Tianjin Jinjin Pharmaceutical Business Overview

11.6.3 Tianjin Jinjin Pharmaceutical Prednisolone Tablets Product Models, Descriptions and Specifications

11.6.4 Tianjin Jinjin Pharmaceutical Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Tianjin Jinjin Pharmaceutical Recent Developments

11.7 China Resources Zizhu Pharmaceutical

11.7.1 China Resources Zizhu Pharmaceutical Corporation Information

11.7.2 China Resources Zizhu Pharmaceutical Business Overview

11.7.3 China Resources Zizhu Pharmaceutical Prednisolone Tablets Product Models, Descriptions and Specifications

11.7.4 China Resources Zizhu Pharmaceutical Prednisolone Tablets Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 China Resources Zizhu Pharmaceutical Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Prednisolone Tablets Industry Chain

12.2 Prednisolone Tablets Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Prednisolone Tablets Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Prednisolone Tablets Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Prednisolone Tablets Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Prednisolone Tablets Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Pfizer Inc

Teva Pharmaceuticals

Harbin Pharmaceutical

Zhejiang Xianju Pharmaceutical

Xi'an Lijun Pharmaceutical

Tianjin Jinjin Pharmaceutical

China Resources Zizhu Pharmaceutical

List of Tables

Table 1. Global Prednisolone Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Prednisolone Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Prednisolone Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Prednisolone Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Prednisolone Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Prednisolone Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Prednisolone Tablets Sales by Region (2020-2025) & (K Units)

Table 8. Global Prednisolone Tablets Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Prednisolone Tablets Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Prednisolone Tablets Sales Share by Manufacturers (2020-2025)

Table 12. Global Prednisolone Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Prednisolone Tablets Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Prednisolone Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prednisolone Tablets as of 2024)

Table 16. Global Prednisolone Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Prednisolone Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Prednisolone Tablets Manufacturing Base and Headquarters

Table 19. Global Prednisolone Tablets Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Prednisolone Tablets Sales by Type (2020-2025) & (K Units)

Table 23. Global Prednisolone Tablets Sales by Type (2026-2031) & (K Units)

Table 24. Global Prednisolone Tablets Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Prednisolone Tablets Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Prednisolone Tablets ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Prednisolone Tablets Sales by Application (2020-2025) & (K Units)

Table 29. Global Prednisolone Tablets Sales by Application (2026-2031) & (K Units)

Table 30. Prednisolone Tablets High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Prednisolone Tablets Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Prednisolone Tablets Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Prednisolone Tablets ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Prednisolone Tablets Growth Accelerators and Market Barriers

Table 37. North America Prednisolone Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Prednisolone Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Prednisolone Tablets Growth Accelerators and Market Barriers

Table 40. Europe Prednisolone Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Prednisolone Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Prednisolone Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Prednisolone Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Prednisolone Tablets Growth Accelerators and Market Barriers

Table 45. Southeast Asia Prednisolone Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Prednisolone Tablets Investment Opportunities and Key Challenges

Table 47. Central and South America Prednisolone Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Prednisolone Tablets Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Prednisolone Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Pfizer Corporation Information

Table 51. Pfizer Description and Major Businesses

Table 52. Pfizer Product Models, Descriptions and Specifications

Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Pfizer Sales Value Proportion by Product in 2024

Table 55. Pfizer Sales Value Proportion by Application in 2024

Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024

Table 57. Pfizer Prednisolone Tablets SWOT Analysis

Table 58. Pfizer Recent Developments

Table 59. Teva Pharmaceuticals Corporation Information

Table 60. Teva Pharmaceuticals Description and Major Businesses

Table 61. Teva Pharmaceuticals Product Models, Descriptions and Specifications

Table 62. Teva Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Teva Pharmaceuticals Sales Value Proportion by Product in 2024

Table 64. Teva Pharmaceuticals Sales Value Proportion by Application in 2024

Table 65. Teva Pharmaceuticals Sales Value Proportion by Geographic Area in 2024

Table 66. Teva Pharmaceuticals Prednisolone Tablets SWOT Analysis

Table 67. Teva Pharmaceuticals Recent Developments

Table 68. Harbin Pharmaceutical Corporation Information

Table 69. Harbin Pharmaceutical Description and Major Businesses

Table 70. Harbin Pharmaceutical Product Models, Descriptions and Specifications

Table 71. Harbin Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Harbin Pharmaceutical Sales Value Proportion by Product in 2024

Table 73. Harbin Pharmaceutical Sales Value Proportion by Application in 2024

Table 74. Harbin Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 75. Harbin Pharmaceutical Prednisolone Tablets SWOT Analysis

Table 76. Harbin Pharmaceutical Recent Developments

Table 77. Zhejiang Xianju Pharmaceutical Corporation Information

Table 78. Zhejiang Xianju Pharmaceutical Description and Major Businesses

Table 79. Zhejiang Xianju Pharmaceutical Product Models, Descriptions and Specifications

Table 80. Zhejiang Xianju Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Zhejiang Xianju Pharmaceutical Sales Value Proportion by Product in 2024

Table 82. Zhejiang Xianju Pharmaceutical Sales Value Proportion by Application in 2024

Table 83. Zhejiang Xianju Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 84. Zhejiang Xianju Pharmaceutical Prednisolone Tablets SWOT Analysis

Table 85. Zhejiang Xianju Pharmaceutical Recent Developments

Table 86. Xi'An Lijun Pharmaceutical Corporation Information

Table 87. Xi'An Lijun Pharmaceutical Description and Major Businesses

Table 88. Xi'An Lijun Pharmaceutical Product Models, Descriptions and Specifications

Table 89. Xi'An Lijun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Xi'An Lijun Pharmaceutical Sales Value Proportion by Product in 2024

Table 91. Xi'An Lijun Pharmaceutical Sales Value Proportion by Application in 2024

Table 92. Xi'An Lijun Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 93. Xi'An Lijun Pharmaceutical Prednisolone Tablets SWOT Analysis

Table 94. Xi'An Lijun Pharmaceutical Recent Developments

Table 95. Tianjin Jinjin Pharmaceutical Corporation Information

Table 96. Tianjin Jinjin Pharmaceutical Description and Major Businesses

Table 97. Tianjin Jinjin Pharmaceutical Product Models, Descriptions and Specifications

Table 98. Tianjin Jinjin Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Tianjin Jinjin Pharmaceutical Recent Developments

Table 100. China Resources Zizhu Pharmaceutical Corporation Information

Table 101. China Resources Zizhu Pharmaceutical Description and Major Businesses

Table 102. China Resources Zizhu Pharmaceutical Product Models, Descriptions and Specifications

Table 103. China Resources Zizhu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. China Resources Zizhu Pharmaceutical Recent Developments

Table 105. Key Raw Materials Distribution

Table 106. Raw Materials Key Suppliers

Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 108. Milestones in Production Technology Evolution

Table 109. Distributors List

Table 110. Market Trends and Market Evolution

Table 111. Market Drivers and Opportunities

Table 112. Market Challenges, Risks, and Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Prednisolone Tablets Product Picture

Figure 2. Global Prednisolone Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Original Drug Product Picture

Figure 4. Generic Drug Product Picture

Figure 5. Global Prednisolone Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Others

Figure 9. Prednisolone Tablets Report Years Considered

Figure 10. Global Prednisolone Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 12. Global Prednisolone Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Prednisolone Tablets Revenue Market Share by Region (2020-2031)

Figure 14. Global Prednisolone Tablets Sales (2020-2031) & (K Units)

Figure 15. Global Prednisolone Tablets Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Prednisolone Tablets Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Prednisolone Tablets Sales Volume Market Share in 2024

Figure 18. Global Prednisolone Tablets Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Original Drug Revenue Market Share by Manufacturer in 2024

Figure 21. Generic Drug Revenue Market Share by Manufacturer in 2024

Figure 22. Global Prednisolone Tablets Sales Market Share by Type (2020-2031)

Figure 23. Global Prednisolone Tablets Revenue Market Share by Type (2020-2031)

Figure 24. Global Prednisolone Tablets Sales Market Share by Application (2020-2031)

Figure 25. Global Prednisolone Tablets Revenue Market Share by Application (2020-2031)

Figure 26. North America Prednisolone Tablets Sales YoY (2020-2031) & (K Units)

Figure 27. North America Prednisolone Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Prednisolone Tablets Sales Revenue (US$ Million) in 2024

Figure 29. North America Prednisolone Tablets Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Prednisolone Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Prednisolone Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Prednisolone Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Prednisolone Tablets Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Prednisolone Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Prednisolone Tablets Sales Revenue (US$ Million) in 2024

Figure 39. Europe Prednisolone Tablets Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Prednisolone Tablets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Prednisolone Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Prednisolone Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 44. France Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Prednisolone Tablets Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Prednisolone Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Prednisolone Tablets Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Prednisolone Tablets Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Prednisolone Tablets Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Prednisolone Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Prednisolone Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 59. India Prednisolone Tablets Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Prednisolone Tablets Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Prednisolone Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Prednisolone Tablets Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Prednisolone Tablets Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Prednisolone Tablets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Prednisolone Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Prednisolone Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Prednisolone Tablets Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Prednisolone Tablets Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Prednisolone Tablets Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Prednisolone Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Prednisolone Tablets Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Prednisolone Tablets Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Prednisolone Tablets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Prednisolone Tablets Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Prednisolone Tablets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Prednisolone Tablets Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Prednisolone Tablets Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Prednisolone Tablets Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Prednisolone Tablets Revenue (2020-2025) & (US$ Million)

Figure 80. Prednisolone Tablets Industry Chain Mapping

Figure 81. Regional Prednisolone Tablets Manufacturing Base Distribution (%)

Figure 82. Global Prednisolone Tablets Production Market Share by Region (2020-2031)

Figure 83. Prednisolone Tablets Production Process

Figure 84. Regional Prednisolone Tablets Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-10O16568

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3G16891

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4B16895

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4D16704

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Prednisolone Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-20R20084

Global Prednisolone Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Prednisolone Tablets Market Size

Prednisolone Tablets Market

Report Includes:

Scope of Prednisolone Tablets Market Report

Chapter Outline

FAQ for this report

How fast is Prednisolone Tablets Market growing?

What is the Prednisolone Tablets Market size in 2031?

Who are the main players in the Prednisolone Tablets Market report?

What are the Application segmentation covered in the Prednisolone Tablets Market report?

What are the Type segmentation covered in the Prednisolone Tablets Market report?

FEATURED COMPANIES

RELATED REPORTS